arrow
V

Vandack Nobre

Universidade Federal de Minas Gerais
H指数:37
被引数:6,298

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

How to apply biomarkers to optimize antibiotic utilization in hospital-acquired pneumonia?

如何应用生物标志物优化医院获得性肺炎的抗生素使用?

2026-11-060
OAAI
Efficacy and Safety of a Digital Clinical Decision Support System Using a C-Reactive Protein–Based Algorithm and Evidence-Based Stopping Rules to Guide Antibiotic Therapy Duration: A Single-Center, Open-Label Randomized Controlled Trial in a Tertiary Care Hospital

数字临床决策支持系统在指导抗生素疗程中的应用效果与安全性:基于C反应蛋白算法和循证停药规则的单中心、开放标签随机对照试验

2026-04-150
OA
One-Year Quality of Life Among Survivors of Hospitalization for Omicron Infection in Brazil: A Multicentre Prospective Cohort Study

巴西奥密克戎感染住院幸存者的一年生活质量:一项多中心前瞻性队列研究

2025-11-180
OAAI
Anti-SARS-CoV-2 Antibodies in Urine of Individuals Vaccinated with Janssen AD26.COV2.S COVID-19 Vaccine

接种Janssen AD26.COV2.S COVID-19疫苗个体尿液中的抗SARS-CoV-2抗体

2025-08-230
PRE
New biomarkers in scorpion stings

蝎子蜇伤的新型生物标志物

2025-02-010
PRE
Red Blood Cell Distribution Width Is Not a Predictor of Hospital Mortality in Elderly and Nonelderly COVID-19-Infected Patients: A Prospective Study at a Brazilian Quaternary University Hospital

红细胞分布宽度不是老年和非老年COVID-19感染患者住院死亡率的预测指标:一项在巴西一所四级大学医院进行的前瞻性研究

2025-01-010
OAAI
Biomarkers in pulmonary infections: a clinical approach

肺部感染中的生物标志物:临床视角

2024-07-174
OAAI
AB2CO risk score for in-hospital mortality of COVID-19 patients admitted to intensive care units
2024-06-010
PRE
Challenges for a broad international implementation of the current severe community-acquired pneumonia guidelines

当前严重社区获得性肺炎指南广泛国际实施面临的挑战

2024-03-283
PRE
Assessment of risk scores to predict mortality of COVID-19 patients admitted to the intensive care unit (vol 10, 1130218, 2023)

评估风险评分以预测重症监护病房新型冠状病毒肺炎患者的死亡率 (第10卷,1130218,2023)

2024-01-310
OAAI
B-Cell Epitopes-Based Chimeric Protein from SARS-CoV-2 N and S Proteins Is Recognized by Specific Antibodies in Serum and Urine Samples from Patients
2023-09-053
OAAI